BW Offshore
BW Offshore: Invitation to presentation of floating offshore wind investment 17 February
With reference to stock exchange release titled - BW Offshore invests in Ideol creating floating offshore wind champion.
BW Offshore and Ideol S.A, represented by CEOs Marco Beenen and Paul de la Guérivière, will today present the transaction and the future strategy of BW Ideol and its floating offshore wind business in a webcast at 10:00 CET.
Click here to access the webcast or dial in at +47 21 40 42 22, phone Conference ID: 974 462 988#. Webcast details can also be found at www.bwoffshore.com.
Please find attached, the recently released statement and the presentation which will be used at today’s webcast.
For further information, please contact:
Anders S. Platou, Head of Corporate Finance, +47 99 50 47 40
IR@bwoffshore.com (mailto:IR@bwoffshore.com) or www.bwoffshore.com
About BW Offshore:
BW Offshore is a leading provider of floating production services to the oil and gas industry. The company also participates in developing proven offshore hydrocarbon reservoirs. BW Offshore is represented in all major oil and gas regions world-wide with a fleet of 15 owned FPSOs. The company has more than 35 years of production track record, having executed 40 FPSO and FSO projects. BW Offshore is listed on the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachments
- 210217 - BW Ideol presentation
- BW Offshore invests in Ideol creating floating offshore wind champion
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ONWARD Medical NV28.4.2025 08:30:00 CEST | Press release
ONWARD Medical Announces Release of 2024 Annual Report
Purespring Therapeutics28.4.2025 08:00:00 CEST | Press release
Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)
FreeMove Alliance28.4.2025 08:00:00 CEST | Press release
FreeMove Alliance and du cooperate to better serve Multinationals in the United Arab Emirates
LIfT BioSciences28.4.2025 08:00:00 CEST | Press release
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
Fingerprint Cards AB28.4.2025 08:00:00 CEST | Press release
Mantra Softech extends licence for FPC iris technology to expand into new markets
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom